Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
Core EBITDA Growth

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2020Mar2019
   Core EBITDA Growth(%) -11.39-4.31173.1965.79-

What is the latest Core EBITDA Growth ratio of SHREE GANESH REMEDIES ?

The latest Core EBITDA Growth ratio of SHREE GANESH REMEDIES is -11.39 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-11.39
Mar2025-4.31
Mar2024173.19
Mar202065.79
Mar2019-

How is Core EBITDA Growth of SHREE GANESH REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2026 -11.39
Negative
Mar2025 -4.31
Negative
Mar2024 173.19
163.25
Mar2020 65.79
0
Mar2019 0 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare Core EBITDA Growth ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹893.7 Cr 5.8% 33.6% 20.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

5.8%

33.6%

20.5%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses